Recombinant IL6 (Clazakizumab Biosimilar) antibody

Catalog No. ABIN7487991

This Mammalian Cells Monoclonal antibody specifically detects IL6 (Clazakizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant IL6 (Clazakizumab Biosimilar) antibody (ABIN7487991)

Target: IL6 (Clazakizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL6 (Clazakizumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL6 (Clazakizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Clazakizumab Biosimilar - Anti-IL6 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IL6 (Clazakizumab Biosimilar)

Target: IL6 (Clazakizumab Biosimilar)

Target Type: Biosimilar

Background: ALD-518,BMS-945429
Clazakizumab (formerly ALD518 and BMS-945429), an investigational drug, is an aglycosylated, humanized rabbit monoclonal antibody against interleukin-6.

CAS-No: 1236278-28-6